CONTINUE TO SITE ➞

Don't miss tomorrow's medtech industry news

Let MedTech Dive's free newsletter keep you informed, straight from your inbox.

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Informa TechTarget |

BioPharma Dive
Healthcare Dive
Xtelligent Health IT

Explore our brands

An Informa TechTarget Publication

Deep Dive
Library
Events
Press Releases

FDA
M&A
Recalls
Earnings
Cybersecurity
AI
Cardiac
Diabetes
Diagnostics

What We're Reading: Page 2

Industry reads hand-picked by our editors

Apr 09, 2026

Health Policy Watch
War in Iran Threatens Helium Supplies for the World’s MRI Machines
Stat
Trump promised to clamp down on health insurers. His policies are enriching them
BioPharma Dive
With 3 quick buyouts, Gilead leans into its latest transformation

Apr 08, 2026

Medical Device Network
Stereotaxis launches Synchrony system for cath labs
Stat
Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it
BioPharma Dive
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis

Apr 07, 2026

Fierce Biotech
Owlet CEO exits suddenly, co-founder returns to the nest
Cybersecurity Dive
Hims & Hers says limited data stolen in social engineering attack
Healthcare Dive
CMS finalizes higher Medicare Advantage rates for 2027 in gift to insurers

Apr 06, 2026

The Wall Street Journal
Why the U.S. Spends So Much on Healthcare
Stat
UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
Healthcare Dive
CMS finalizes Medicare Advantage star ratings overhaul, sending billions of dollars more to insurers

Apr 03, 2026

Supply Chain Dive
Trump slaps steep tariffs on patented drug imports
BioPharma Dive
FDA approves Lilly obesity pill, triggering battle with Novo Nordisk
KFF Health News
Tax Time Brings Surprises for Some Who Receive ACA Subsidies

Apr 02, 2026

STAT
How the FDA’s stance on breakthrough AI is evolving
MobiHealthNews
Samsung releases Galaxy Watch blood pressure feature in U.S.
BioPharma Dive
FDA approves Lilly obesity pill, triggering battle with Novo Nordisk

Apr 01, 2026

MassDevice
Olympus makes trio of executive changes including at CFO
BioPharma Dive
A ‘hijacked plane’: CDC, under RFK Jr.’s influence, trades science for dogma
BioPharma Dive
FDA, after turbulent year, leaves drugmakers guessing on its direction

Previous Next

Get the free newsletter

Subscribe to MedTech Dive for top news, trends & analysis

Email:

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Take your knowledge further with

Interested? Explore more of what has to offer.

You're all set

Thanks for signing up! Please keep an eye out for a confirmation email from [email protected] To ensure we make it into your inbox regularly, add us to your allow list, mark us as a safe sender, or add us to your address book. Check out more from

Library resources

Survey Report
Avoiding Costly Protocol Amendments: Strategies for Sponsors Custom content for Premier Research
Trendline
How AI tools are transforming the medtech space Supported by Nuance Communications
The MedTech Dive Outlook on 2026

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

BioPharma Dive
Healthcare Dive
Xtelligent Health IT

This website is owned and operated by Informa TechTarget, a global network that informs, influences and connects the world's technology buyers and sellers.

Home
- FDA
- M&A
- Recalls
- Earnings
- Cybersecurity
- AI
- Cardiac
- Diabetes
- Diagnostics
Deep Dive
Library
Events
Press Releases

Get MedTech Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.